Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in “Using Synthetic Biology to Battle Mpox” Talk at Immunology Symposium at the University of Alberta
September 09, 2024 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
TNX-801 vaccination demonstrated efficacy in protecting animals from lethal challenge with clade I monkeypox and is in development as an mpox vaccine New data show improved tolerability in...
Acrivon Therapeutics to Host Virtual Investor Event to Review Positive Phase 2 Clinical Data of ACR-368 Presented at ESMO and Pipeline Progress, Including Clinical Candidate ACR-2316
September 09, 2024 07:00 ET
|
Acrivon Therapeutics, Inc
-Webcast investor event on September 14, 2024 at 9:00 a.m. ET -ESMO poster presentation to provide updated ACR-368 clinical data in endometrial cancer -Webcast to provide updates on its lead assets...
Akero Therapeutics Announces First Patient Dosed in Phase 3 SYNCHRONY Outcomes Study of Efruxifermin in Patients with Compensated Cirrhosis Due to MASH
September 09, 2024 07:00 ET
|
Akero Therapeutics Inc.
Outcomes is the third study in the Phase 3 SYNCHRONY clinical trial program SOUTH SAN FRANCISCO, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a...
Tilray Medical unterstützt wissenschaftliche Studie zu Fibromyalgie Mit positiven Ergebnissen: Wirksamkeit der Cannabinoid-Behandlung von Schmerzen und anderen mit Fibromyalgie verbundenen Symptomen
September 09, 2024 07:00 ET
|
Tilray Brands, Inc.
LISSABON, Portugal, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. („Tilray“) (Nasdaq: TLRY; TSX: TLRY) und ein weltweit führender Anbieter von...
MoonLake Immunotherapeutics to host a Capital Markets Update on Wednesday, September 11
September 09, 2024 07:00 ET
|
MoonLake Immunotherapeutics AG
MoonLake Immunotherapeutics to host a Capital Markets Updateon Wednesday, September 11ZUG, Switzerland, September 9, 2024 – MoonLake Immunotherapeutics AG (“MoonLake”; Nasdaq: MLTX), a clinical-stage...
Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
September 09, 2024 06:55 ET
|
Relay Therapeutics, Inc.
Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
Ocugen Chairman, CEO & Co-founder, Dr. Shankar Musunuri, to Speak During U.S.-India Initiative on Critical and Emerging Technology Workshop
September 09, 2024 06:30 ET
|
Ocugen
MALVERN, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene...
Bitfarms Reschedules Special Meeting of Shareholders
September 09, 2024 06:15 ET
|
Bitfarms Ltd.
- Provides Update on Engagement with Riot -- Special Meeting to be Held In-Person - This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement...
reAlpha Acquires Mortgage Brokerage Company Be My Neighbor
September 09, 2024 06:00 ET
|
reAlpha Tech Corp.
Strategic acquisition strengthens reAlpha’s vertically integrated real estate technology platform. DUBLIN, Ohio, Sept. 09, 2024 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (“reAlpha”) (Nasdaq: AIRE), a...
THE RAGNAROK Official Launching in South Korea on September 9, 2024
September 09, 2024 06:00 ET
|
GRAVITY Co., Ltd.
Seoul, Sept. 09, 2024 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd (NASDAQGM: GRVY) (‘Gravity’ or ‘Company’), a developer and publisher of online and mobile games, announced the official launch of ‘THE...